EAdjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

被引：223

作者：

Kris, Mark G. ^{[2
]}

Gaspar, Laurie E. ^{[5
]}

Chaft, Jamie E. ^{[2
]}

Kennedy, Erin B. ^{[1
]}

Azzoli, Christopher G. ^{[6
]}

Ellis, Peter M. ^{[10
]}

Lin, Steven H. ^{[7
]}

Pass, Harvey I. ^{[3
]}

Seth, Rahul ^{[4
]}

Shepherd, Frances A. ^{[11
]}

Spigel, David R. ^{[9
]}

Strawn, John R. ^{[8
]}

Ung, Yee C. ^{[12
]}

Weyant, Michael ^{[5
]}

机构：

[1] Amer Soc Clin Oncol, 2318 Mill Rd,Suite 800, Alexandria, VA 22314 USA

[2] Mem Sloan Kettering Canc Ctr, Hauppauge, NY USA

[3] NYU, Langone Med Ctr, New York, NY USA

[4] Syracuse Univ, Upstate Med Ctr, Syracuse, NY USA

[5] Univ Colorado, Sch Med, Aurora, CO USA

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] MD Anderson Canc Ctr, Houston, TX USA

[8] Patient Representat, Houston, TX USA

[9] Sarah Cannon Canc Ctr, Nashville, TN USA

[10] Juravinski Canc Ctr, Hamilton Hlth Sci, Hamilton, ON, Canada

[11] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[12] Sunnybrook Reg Canc Ctr, Toronto, ON, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 25期

关键词：

TYROSINE KINASE INHIBITORS; POSTOPERATIVE RADIOTHERAPY; INTERNATIONAL ASSOCIATION; INDEPENDENT PREDICTOR; PROGNOSTIC MARKER; POOLED ANALYSIS; BAD-NEWS; CHEMOTHERAPY; ADENOCARCINOMA; CLASSIFICATION;

D O I：

10.1200/JCO.2017.72.4401

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose The panel updated the American Society of Clinical Oncology (ASCO) adjuvant therapy guideline for resected non-small-cell lung cancers. Methods ASCO convened an update panel and conducted a systematic review of the literature, investigating adjuvant therapy in resected non-small-cell lung cancers. Results The updated evidence base covered questions related to adjuvant systemic therapy and included a systematic review conducted by Cancer Care Ontario current to January 2016. A recent American Society for Radiation Oncology guideline and systematic review, previously endorsed by ASCO, was used as the basis for recommendations for adjuvant radiation therapy. An update of these systematic reviews and a search for studies related to radiation therapy found no additional randomized controlled trials. Recommendations Adjuvant cisplatin-based chemotherapy is recommended for routine use in patients with stage IIA, IIB, or IIIA disease who have undergone complete surgical resections. For individuals with stage IB, adjuvant cisplatin-based chemotherapy is not recommended for routine use. However, a postoperative multimodality evaluation, including a consultation with a medical oncologist, is recommended to assess benefits and risks of adjuvant chemotherapy for each patient. The guideline provides information on factors other than stage to consider when making a recommendation for adjuvant chemotherapy, including tumor size, histopathologic features, and genetic alterations. Adjuvant chemotherapy is not recommended for patients with stage IA disease. Adjuvant radiation therapy is not recommended for patients with resected stage I or II disease. In patients with stage IIIA N2 disease, adjuvant radiation therapy is not recommended for routine use. However, a postoperative multimodality evaluation, including a consultation with a radiation oncologist, is recommended to assess benefits and risks of adjuvant radiation therapy for each patient with N2 disease. (C) 2017 by American Society of Clinical Oncology

引用

页码：2960 / +

页数：17

共 79 条

[1]

Al-Alao Bassel S, 2014, Asian Cardiovasc Thorac Ann, V22, P55, DOI 10.1177/0218492313478431

[2]

ALBERTI W, 1995, BRIT MED J, V311, P899

[3]

American Society of Clinical Oncology, 2003, J Clin Oncol, V21, P2777

[4] Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer [J].

Arriagada, Rodrigo ;

Dunant, Ariane ;

Pignon, Jean-Pierre ;

Bergman, Bengt ;

Chabowski, Mariusz ;

Grunenwald, Dominique ;

Kozlowski, Miroslaw ;

Le Pechoux, Cecile ;

Pirker, Robert ;

Pinel, Maria-Izabel Sathler ;

Tarayre, Michele ;

Le Chevalier, Thierry .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :35-42

[5] Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art [J].

Artal Cortes, Angel ;

Calera Urquizu, Lourdes ;

Hernando Cubero, Jorge .

TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) :191-197

[6] Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data [J].

Auperin, A. ;

Le Chevalier, T. ;

Le Pechoux, C. ;

Pignon, J. P. ;

Tribodet, H. ;

Burdett, S. ;

Stewart, L. A. ;

Tierney, J. F. ;

Stephens, R. J. ;

Arriagada, R. ;

Higgins, J. P. ;

Johnson, D. H. ;

van Meerbeeck, J. ;

Parmar, M. K. B. ;

Souhami, R. L. ;

Bergman, B. ;

Dautzenberg, B. ;

Douillard, J. Y. ;

Dunant, A. ;

Endo, C. ;

Girling, D. J. ;

Imaizumi, M. ;

Kato, H. ;

Keller, S. M. ;

Kimura, H. ;

Knuuttila, A. ;

Kodama, K. ;

Komaki, R. ;

Kris, M. G. ;

Lad, T. ;

Mineo, T. ;

Park, J. H. ;

Piantadosi, S. ;

Pyrhonen, S. ;

Rosell, R. ;

Scagliotti, G. V. ;

Seymour, L. W. ;

Shepherd, F. A. ;

Spiro, S. G. ;

Strauss, G. M. ;

Sylvester, R. ;

Tada, H. ;

Tanaka, F. ;

Torri, V. ;

Wada, H. ;

Waller, D. ;

Xu, G. C. .

LANCET, 2010, 375 (9722) :1267-1277

[7] Gene-expression profiles predict survival of patients with lung adenocarcinoma [J].

Beer, DG ;

Kardia, SLR ;

Huang, CC ;

Giordano, TJ ;

Levin, AM ;

Misek, DE ;

Lin, L ;

Chen, GA ;

Gharib, TG ;

Thomas, DG ;

Lizyness, ML ;

Kuick, R ;

Hayasaka, S ;

Taylor, JMG ;

Iannettoni, MD ;

Orringer, MB ;

Hanash, S .

NATURE MEDICINE, 2002, 8 (08) :816-824

[8] A Phase 2 Cooperative Group Adjuvant Trial Using a Biomarker-Based Decision Algorithm in Patients With Stage I Non-Small Cell Lung Cancer (SWOG-0720, NCT00792701) [J].

Bepler, Gerold ;

Zinner, Ralph G. ;

Moon, James ;

Calhoun, Royce ;

Kernstine, Kemp ;

Williams, Charles C. ;

Mack, Philip C. ;

Oliveira, Vasco ;

Zheng, Zhong ;

Stella, Philip J. ;

Redman, Mary W. ;

Gandara, David R. .

CANCER, 2014, 120 (15) :2343-2351

[9] Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer [J].

Bepler, Gerold ;

Williams, Charles ;

Schell, Michael J. ;

Chen, Wei ;

Zheng, Zhong ;

Simon, George ;

Gadgeel, Shirish ;

Zhao, Xiuhua ;

Schreiber, Fred ;

Brahmer, Julie ;

Chiappori, Alberto ;

Tanvetyanon, Tawee ;

Pinder-Schenck, Mary ;

Gray, Jhanelle ;

Haura, Eric ;

Antonia, Scott ;

Fischer, Juergen R. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) :2404-+

[10] Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline [J].

Bezjak, Andrea ;

Temin, Sarah ;

Franklin, Gregg ;

Giaccone, Giuseppe ;

Govindan, Ramaswamy ;

Johnson, Melissa L. ;

Rimner, Andreas ;

Schneider, Bryan J. ;

Strawn, John ;

Azzoli, Christopher G. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18) :2100-U162

← 1 2 3 4 5 6 7 8 →